Clik here to view.
3DHISTECH and Epredia Open Pathology Innovation Incubator to Accelerate...
BUDAPEST, Hungary Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group (headquartered in Japan), announce the opening of the Pathology Innovation...
View ArticleClik here to view.
Incyte Announces Japanese Approval of Pemazyre® (pemigatinib) for the...
WILMINGTON, Del. & TOKYO Incyte (Nasdaq:INCY) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Pemazyre® (pemigatinib), a selective fibroblast growth...
View ArticleClik here to view.
知临集团签署意向书及投资条件书以收购U Group
NEW YORK & LONDON & PARIS (美国商业资讯) — 知临集团 (纳斯达克代码：APM，欧洲巴黎证券交易所代码：APM) (「知临集团」或「知临」) ，今天宣布，通过发行其A类普通股作为对价，签署了非约束性意向书和投资条件书(「交易」)，以收购URF Holding Group Limited及其基础业务(统称为「U Group」)的100%股权。U...
View ArticleClik here to view.
Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group
NEW YORK & LONDON & PARIS Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Company”), today announced that it entered into a non-binding Letter...
View ArticleClik here to view.
InnoCare Releases 2022 Annual Results and Business Highlights
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2022 annual results as of 31 December 2022. Dr....
View ArticleClik here to view.
インサイト、「ペマジール®」（ペミガチニブ）が骨髄／リンパ性腫瘍（MLN）患者の治療薬として日本で承認されたと発表
米デラウェア州ウィルミントン & 東京 （ビジネスワイヤ） — インサイト(Nasdaq:INCY)...
View ArticleClik here to view.
Clik here to view.
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders...
OSAKA, Japan Takeda (TSE:4502/NYSE:TAK) announced that its Board of Directors today decided that it will propose a new candidate for independent external director at the 147th Ordinary Meeting of...
View ArticleClik here to view.
BeiGene Appoints Julius Pryor III as First Global Head of Diversity and...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the appointment of Julius Pryor III as its...
View ArticleClik here to view.
NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug...
TOKYO & HILVERSUM, Netherlands & OSLO, Norway & MANNHEIM, Germany NEC Corporation (NEC, TOKYO: 6701) announced in 2019 that it would expand the application of its cutting-edge AI...
View ArticleClik here to view.
武田宣布将在即将召开的股东大会上公布董事会候选人
日本大阪 (美国商业资讯)–武田(Takeda)(TSE:4502/NYSE:TAK)宣布，公司董事会今天决定，董事会将在2023年6月28日举行的第147次普通股东大会上提议一名新的独立外部董事候选人。如果得到股东的批准，新候选人Miki Tsusaka将于6月28日加入董事会。此外，日本总务部代表董事Masato...
View ArticleClik here to view.
REGiMMUNE Limited Licenses the Rights to Develop and Commercialize RGI-2001...
TAIPEI, Taiwan REGiMMUNE Limited (REGiMMUNE), a biotech company focused on creating innovative immunotherapies for immune disorders and cancer, and San Fu Biotech (SFB), a subsidiary of San Fu...
View ArticleClik here to view.
Wyss Center（ジュネーブ）、新CEOにアーウィン・ベッティンガー氏を任命
ジュネーブ （ビジネスワイヤ） — 非営利の研究所であるWyss Center for Bio and Neuroengineeringの理事会は、医学博士であるアーウィン・ベッティンガー氏を新たな最高執行責任者（CEO）に任命したことを発表しました。...
View ArticleClik here to view.
Wyss Center（日内瓦）任命Erwin Böttinger为新一任首席执行官
日内瓦 (美国商业资讯)–非营利研究中心Wyss Center for Bio and Neuroengineering执行董事会很高兴地宣布，任命医学博士Erwin Böttinger教授为新一任首席执行官(CEO)。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20230331005255/zh-CN/...
View ArticleClik here to view.
InnoCare Announces First Subject Dosed in Clinical Trial of Novel Targeted...
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first subject has been...
View ArticleClik here to view.
PHC株式会社：非黒色腫皮膚がん分野における検査機器の共同開発に向けた実現性検討をNovaScan, Inc.と開始
東京 （ビジネスワイヤ） — PHC株式会社（本社：東京都港区、代表取締役社長：中村 伸朗、以下「PHC」）と、NovaScan, Inc.（本社：イリノイ州・シカゴ、CEO：Craig Davis、以下「NovaScan」）は、このたび、病理診断領域の非黒色腫皮膚がん分野における生体外検査機器「MarginScanTM」の共同開発に向けて、実現性検討を開始しましたので、お知らせします。...
View ArticleClik here to view.
PHC Corporation and NovaScan, Inc. Launch Collaboration to Explore the...
TOKYO PHC Corporation (headquarters: Minato-ku, Tokyo, President: Nobuaki Nakamura, hereafter PHC) and NovaScan, Inc. (headquarters: Chicago, Illinois, CEO: Craig Davis, hereafter NovaScan) announce...
View ArticleClik here to view.
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders...
OSAKA, Japan Takeda (TSE:4502/NYSE:TAK) announced that its Board of Directors today decided that it will propose a new candidate for independent external director at the 147th Ordinary Meeting of...
View ArticleClik here to view.
BeiGene Appoints Julius Pryor III as First Global Head of Diversity and...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the appointment of Julius Pryor III as its...
View ArticleClik here to view.
NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug...
TOKYO & HILVERSUM, Netherlands & OSLO, Norway & MANNHEIM, Germany NEC Corporation (NEC, TOKYO: 6701) announced in 2019 that it would expand the application of its cutting-edge AI...
View Article